Alles wat je belangrijk vindt op één plek

Volg feeds: blogs, nieuws, RSS en meer. Een moeiteloze manier om content naar keuze te lezen en bij te houden.

Download Feeder

Oncologie RSS-feeds

De RSS-feeds over Oncologie die Feeder-gebruikers het meest volgen, waaronder ClinicalTrials.gov: "ONCOLOGY" | Phase: Early Phase 1, 1, 2, 3 | First posted on or after 05/13/2025 | First posted in the last 14 days, Outpace Bio News en Oncoinvent News and Events. Kopieer een feed-URL of volg ze gratis in Feeder.

Gerelateerde onderwerpen

Gezondheid RSS-feeds Klinische onderzoeken RSS-feeds Medisch onderzoek RSS-feeds Mentale gezondheid RSS-feeds Psychologie RSS-feeds Volksgezondheid RSS-feeds Farma RSS-feeds

Stel een wijziging voor

ClinicalTrials.gov: "ONCOLOGY" | Phase: Early Phase 1, 1, 2, 3 | First posted on or after 05/13/2025 | First posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: "ONCOLOGY" | Phase: Early Phase 1, 1, 2, 3 | First posted on or after 05/13/2025 | First posted in the last 14 days

Nature Reviews Drug Discovery AND cancer

pubmed.ncbi.nlm.nih.gov

Nature Reviews Drug Discovery AND cancer: Latest results from PubMed

ClinicalTrials.gov: Other terms: HER-2/HER2 | Antibody-drug conjugate \(ADC\) | Funded by Industry | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Other terms: HER-2/HER2 | Antibody-drug conjugate \(ADC\) | Funded by Industry | Last update posted in the last 14 days

ClinicalTrials.gov: Other terms: "TCE" OR "T Cell Engager" OR "T-Cell Engager" | Interventional studies | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Other terms: "TCE" OR "T Cell Engager" OR "T-Cell Engager" | Interventional studies | Last update posted in the last 14 days

Frontiers in Oncology | New and Recent Articles

frontiersin.org

RSS Feed for Frontiers in Oncology | New and Recent Articles

bioRxiv Subject Collection: Cancer Biology

biorxiv.org

This feed contains articles for bioRxiv Subject Collection "Cancer Biology"

ClinicalTrials.gov: Other terms: KRAS G12D | Funded by Industry | First posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Other terms: KRAS G12D | Funded by Industry | First posted in the last 14 days

ClinicalTrials.gov: Other terms: KRAS | Funded by Industry | First posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Other terms: KRAS | Funded by Industry | First posted in the last 14 days

ClinicalTrials.gov: Other terms: CEA | Funded by Industry | First posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Other terms: CEA | Funded by Industry | First posted in the last 14 days

ClinicalTrials.gov: "cervical cancer" | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: "cervical cancer" | Last update posted in the last 14 days

ClinicalTrials.gov: TAK228 | Studies updated in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: TAK228 | Last update posted in the last 14 days

Business Wire - News by Company: Incyte Corporation

businesswire.com

Business Wire - The global leader in news distribution

Cancer Currents: An NCI Cancer Research Blog

cancer.gov

<p>A blog featuring news and research updates from the National Cancer Institute.</p>

medrxiv Subject Collection: Oncology

medrxiv.org

This feed contains articles for medRxiv Subject Collection "Oncology"

ClinicalTrials.gov: cetrelimab | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: cetrelimab | Last update posted in the last 14 days

ClinicalTrials.gov: toripalimab | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: toripalimab | Last update posted in the last 14 days

ClinicalTrials.gov: tislelizumab | First posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: tislelizumab | First posted in the last 14 days

Cancer Gene Therapy

nature.com

<em>Cancer Gene Therapy</em> is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA &amp; ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair. <em>Cancer Gene Therapy</em> publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Articles published include the fields of drug resist

ClinicalTrials.gov: enfortumab | First posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: enfortumab | First posted in the last 14 days

ClinicalTrials.gov: enfortumab | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: enfortumab | Last update posted in the last 14 days

ClinicalTrials.gov: SKB410 | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: SKB410 | Last update posted in the last 14 days

ClinicalTrials.gov: CRB-701 | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: CRB-701 | Last update posted in the last 14 days

ClinicalTrials.gov: LY4052031 | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: LY4052031 | Last update posted in the last 14 days

ClinicalTrials.gov: MK-3120 | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: MK-3120 | Last update posted in the last 14 days

ClinicalTrials.gov: Cervical Cancer | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Cervical Cancer | Last update posted in the last 14 days

ClinicalTrials.gov: ovarian | Not yet recruiting, Recruiting studies | Phase: 2, 3 | Interventional studies | Study start on or after 01/01/2023 | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: ovarian | Not yet recruiting, Recruiting studies | Phase: 2, 3 | Interventional studies | Study start on or after 01/01/2023 | Last update posted in the last 14 days

ClinicalTrials.gov: Other terms: Pfizer | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Other terms: Pfizer | Last update posted in the last 14 days

ClinicalTrials.gov: Other terms: Sanofi | Last update posted in the last 14 days

clinicaltrials.gov

Studies found on ClinicalTrials.gov by a search of: Other terms: Sanofi | Last update posted in the last 14 days